CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission
-
Jun 2018
-
-
Source: Emerg Infect Dis. 24(6):1045-1054.
[PDF-1.39 MB]
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We conducted a multicenter, retrospective cohort study of hospitalized patients with serologically proven nephropathia epidemica (NE) living in Ardennes Department, France, during 2000-2014 to develop a bioclinical test predictive of severe disease. Among 205 patients, 45 (22.0%) had severe NE. We found the following factors predictive of severe NE: nephrotoxic drug exposure (p = 0.005, point value 10); visual disorders (p = 0.02, point value 8); microscopic or macroscopic hematuria (p = 0.04, point value 7); leukocyte count >10 × 10| cells/L (p = 0.01, point value 9); and thrombocytopenia <90 × 10|/L (p = 0.003, point value 11). When point values for each factor were summed, we found a score of <10 identified low-risk patients (3.3% had severe disease), and a score >20 identified high-risk patients (45.3% had severe disease). If validated in future studies, this test could be used to stratify patients by severity in research studies and in clinical practice.
-
Subjects:
-
Source:
-
Pubmed ID:29774835
-
Pubmed Central ID:PMC6004848
-
Document Type:
-
Place as Subject:
-
Volume:24
-
Issue:6
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
